*Together with
Good day, 360 –
Here are our TOP investing ideas today – and don’t forget your FREE invitation ? to join Jeff Bishop at 11am EST for his #1 trade idea breakdown of the week –> add event HERE.
TSLA – Down 2% in pre-market after delivery numbers
GFAI – 2nd day play, closed over 45% higher and gapping up 26% today as AI mania returns
INDO – Up over 30% in pre-market as oil rockets on OPEC+ production cuts
*A Message on Behalf of Mainz Biomed
? Hot Stock of the Day ?
You probably saw that the two stocks we featured last week both gained over 40% after we showed them to you. Good for you if you got a piece of that action!
Maybe the 360 team has a stock-picking crystal ball? ?
Sorry, no magic tricks here. If one of our partners brings us a stock idea, and we love it, then we’re just excited to bring it to your attention as well!
? That brings us to today’s new idea – Mainz Biomed (MYNZ).
There are a few things that are great about this stock right now…
1. MYNZ is attacking a market for testing kits where the only competitor has cornered over $1 billion in sales so far.
2. The average analyst price target for MYNZ is over 218% higher than current levels (2 analysts reiterated their targets last week).
3. MYNZ took advantage of “frothy” markets and raised over $22 million when the stock was trading over double the price it is today.
MYNZ already has its product available in Europe and is currently enrolling people for its study here in the good ol’ US of A. They expect to have results very soon, sometime in the next few months. ?
MYNZ is one of those overlooked opportunities that is really worth your attention right now.
So, go do your homework on it right now while it is still at this price!
*Sponsored by Awareness Consulting Group, please see disclosures below.
TSLA – Down 2% in pre-market after delivery numbers
Tesla reported delivery numbers of 422,875 electric vehicles in Q1 2022 vs the FactSet consensus of 432,000. However, overall analyst estimates put the estimate at 421,164. These mixed estimates see TSLA down 2% in pre-market trade.
For the same period last year, Tesla delivered 310,000 EV units and a record 405,278 vehicles in the fourth quarter of 2022. Despite the miss, TSLA continues to grow deliveries with year-over-year deliveries, growing 40% to 1.31 million. Despite the initial reaction to the news, it appears TSLA continues to have a positive outlook for the future.
Goldman maintained its Buy rating on the stock and raised its 12-month price target to $225 from $200.
The $199-$200.50 area was resistance last week and should prove to be an important pivot level/potential support today.
Above $200.50, targets to the upside are $204.50 which was resistance in the pre-market and support Friday. Then there is a gap to fill at $207.46 with $210, $214, $217.50 and $223.50 targets above that.
Below $199, potential targets to the downside are $197.30, $195, $190 and $187 with $185.43 below that.
GFAI – 2nd day play, closed over 45% higher and gapping up 26% today as AI mania returns
Guardforce AI (GFAI) exploded out of a base on Friday ? and continues higher in pre-market as interest in AI stocks returns. The interest comes as one of the artificial favorites, C3.ai (AI), made 52-week highs on a risk-on day for tech stocks. The strength in AI sent low price stocks such as GFAI higher.
The AI basket of stocks such as AI, GFAI, and BBAI should be on watch.
The $9 area has been resistance in the pre-market so far and should be a level of interest.
Above it the first targets for bulls should be the after hours high of $10.26. Above that $10.63, $12 and $13 come into play.
Below $9 there is potential support at Friday’s high of $7.60, a gap to fill at $7.08, with $6.50 and $6 potential support areas below that. $5.50 is also a major area of potential support.
INDO – Up over 30% in pre-market as oil rockets on OPEC+ production cuts
Oil futures are up over 6.5% this morning after Saudi Arabia and other OPEC+ producers announced a surprise cut in their output target. Oil stocks are in play on the news, and spec play Indonesia Energy (INDO) is one of the biggest movers trading over 30% higher in the pre-market.
$6.63 was a resistance level in the pre-market and should be an important pivot point today.
Above it, targets to the upside are the pre-market high of $6.79 with $6.93, $7.15, $7.50, $8.20. $8.50, $9 and $9.30 potential areas of resistance.
Below $6.63 potential areas of support are at $6.30, $6.22, $5.95, $5.81, $5.50 and a gap to fill at $4.77.
Economic Calendar (EST)
8:30am Fed Speaker James Bullard
9:45am PMI Manufacturing Final
10:00am ISM Manufacturing Index
10:00am Construction Spending
12:30pm Investor Movement Index
4:15pm Fed Speaker Lisa Cook
Earnings for Today (After Market)
BLTE, GNLN, PRPO, SBET, TSSI
Top Headlines
LI Li Auto: 20,800 new vehicles delivered in March, cumulative deliveries exceed 300,000 units
XPEV XPENG – TOTAL DELIVERIES FOR Q1 OF 2023 REACHED 18,230 VEHICLES.
NIO delivered 31,041 vehicles in the three months ended March 2023, increasing by 20.5% year-over-year. Cumulative deliveries of NIO vehicles reached 320,597 as of March 31, 2023
TSLA TESLA Q1 DELIVERY NUMBERS, DELIVERIES 422,875. EST. 421,164.
TSLA Q1 earnings will be released on Wednesday, April 19th
UBS plans to cut as many as 36,000 jobs globally from its combined bank with Credit Suisse, Swiss newspaper SoZ reported BBG
MDT DVA Medtronic, DaVita launch Mozarc Medical, aimed at introducing new solutions for patients with kidney failure.
TVTX Travere Therapeutics Announces Interim Analysis from the Phase 3 PROTECT Study of FILSPARI(TM) (Sparsentan) in IgA Nephropathy Published in The Lancet and Presented at World Congress of Nephrology 2023
WIX Wix Integrates with Amazon in India Enabling Merchants to Expand Their Sales
IPHA Innate Pharma Announces Exclusive License of Antibodies to Takeda for Celiac Disease Research Program
ACN Unilever Goes Cloud-Only: Accenture and Microsoft Complete One of the Largest Cloud Migrations in Consumer Goods Industry
ESLT Elbit Systems Awarded Contract to Supply Precision Munitions and Defense Electronics Systems to a European Country Worth Approximately Million $280
LSI Extra Space Storage to Merge With Life Storage in $12.7 Billion All-Stock Transaction, Executives Confirm — WSJ Deal Values Life Storage at $145.82 per Share, Executives Confirm – WSJ
BIDU Baidu Maps’ next-generation version, V18, was released today, which is supported by the ERNIE Traffic large-scale model and generative AI
CMI Cummins Announces Investments of more than $1 billion Across U.S. Manufacturing Network
SPRU Spruce Power receives notice for non-compliance with NYSE continued Listing standard
BIIB: U.S. National Institute On Aging Is Funding A 6-year, Up To $300M Project To Build A Massive Alzheimer’s Research Database
NKLA Nikola Corporation Announces Proposed Public Offering of up to 89.3 Million Common Shares – SEC Filing
TGL: Treasure Global Signs Letter of Intent with Southern Hospitality Restaurant Chain, Morganfield’s to Adopt TAZTE and Lease its Branding Rights
PRMW: Primo Water Files Definitive Proxy Statement and Issues Letter to Shareowners Highlighting the Company’s Transformation and Business Progress
EXR LSI: Extra Space Storage & Life Storage Combine to Form the Preeminent Storage Operator
VNTR Venator Completes Divestiture of Iron Oxide Business
AULT: Ault Alliance’s Subsidiary, Ault Energy, LLC, Strikes Oil on First Two Joint Drilling Projects, Suggesting a Bright Future With More Wells in the Pipeline
BNTX: BioNTech and DualityBio Form Global Strategic Partnership to Accelerate Development of Differentiated Antibody-Drug Conjugate Therapeutics for Solid Tumors
EDR Endeavor Announces UFC(R) and WWE(R) to Form a $21+ Billion Global Live Sports and Entertainment Company
TECK: Teck Board of Directors Rejects Unsolicited Acquisition Proposal
DNA: Sensible Biotechnologies Announces Partnership with Ginkgo Bioworks to Develop Novel mRNA Manufacturing Platform
TNGX Tango Therapeutics Announces FDA Clearance of Investigational New Drug Application for TNG260, a First-in-Class CoREST Inhibitor for the Treatment of STK11-Mutant Cancers
PSNY: Polestar reduces relative CO2 emissions by eight percent in continued efforts to decouple business growth from increased emissions
SSYS: Stratasys Board of Directors Unanimously Rejects the Nano Dimension Revised Unsolicited Proposal of $19.55 Per Share
FGEN: FibroGen Announces Completion of Patient Enrollment in ZEPHYRUS-2, a Phase 3 Clinical Study of Pamrevlumab in Idiopathic Pulmonary Fibrosis
To Your Success!
Questions or concerns about our products? Email [email protected] (C) Copyright 2022, RagingBull – Refund Policy – Privacy Policy – Terms & Conditions
*PAID ADVERTISEMENT. RagingBull has been paid twenty-two thousand five-hundred dollars by ach bank transfer by Awareness Consulting Group for advertising Mainz Biomed from a period beginning on April 3 , 2023 through April 6 of the same year. As a result of this advertisement and other marketing efforts, Raging Bull may receive advertising revenue from new advertisers and collect email addresses from readers that it may be able to monetize. As of the date of this advertisement, the owners of Raging Bull, do not hold a position in Mainz Biomed. This advertisement and other marketing efforts may increase investor and market awareness, which may result in an increased number of shareholders owning and trading the securities of Mainz Biomed, increased trading volume, and possibly an increased share price of the Mainz Biomed securities, which may or may not be temporary and decrease once the marketing arrangement has ended.
FOR EDUCATIONAL AND INFORMATION PURPOSES ONLY; NOT INVESTMENT ADVICE. This advertisement is for educational and informational purposes only. All material information contained in this advertisement is based on information generally available to the public, which public information is believed to be reliable and accurate. Nevertheless, Raging Bull can guarantee the accuracy or completeness of the information. This advertisement does not purport to be a complete analysis of any company’s financial position. This advertisement or any statements made in it is not, and should not be construed to be, personalized investment advice directed to or appropriate for any particular individual. The statements made in this advertisement should NOT be relied upon for purposes of investing in the companies mentioned in this advertisement, nor should they be construed as a personalized recommendation to you to buy, sell, or hold any position in any security mentioned in this advertisement or in any other security or strategy. It is strongly recommended that you consult a licensed or registered professional before making any investment decision.
SUBSTANTIAL RISK INVOLVED. Any individual who chooses to invest in any securities of the companies mentioned in this advertisement should do so with caution. Investing or transacting in any securities involves substantial risk; you may lose some, all, or possibly more than your original investment. Readers of this advertisement bear responsibility for their own investment research and decisions, and should use information from this advertisement only as a starting point for doing additional independent research in order to allow individuals to form their own opinion regarding investments. It is easy to lose money investing or trading, and we recommend always seeking individual advice from a licensed or registered professional and educating yourself as much as possible before considering any investments.
Our reports/releases are a commercial advertisement and are for general information purposes ONLY. A portion of our business is engaged in the marketing and advertising companies for monetary compensation. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our services, joining our site or our email/blog list as well as any social networking platforms we may use. A portion of RagingBull’s business model is to receive financial compensation to promote public companies. To conduct investor relations advertising, marketing and publicly disseminate information not limited to our websites, email, SMS, push notifications. This compensation is a major conflict of interest in our ability to provide unbiased reporting. Therefore, this communication should be viewed as a commercial advertisement only. Note, we periodically conduct interviews and issue stock alerts that we are not compensated for. These are purely for the purpose of company awareness, and to generate subscription revenues. We have not investigated the background of the hiring third party or parties. The third party, profiled company, or their affiliates likely wish to liquidate shares of the profiled company at or near the time you receive this communication, which has the potential to hurt share prices. Frequently, companies profiled in our alerts may experience a large increase in volume and share price during the course of investor relations marketing, which may end as soon as the corporate awareness program ceases. Our emails may contain forward-looking statements, which are not guaranteed to materialize due to a variety of factors. We do not guarantee the timeliness, accuracy, or completeness of the information on our website / media webpage. The information in our website / media webpage is believed to be accurate and correct but has not been independently verified and is not guaranteed to be correct.
NOT AN INVESTMENT ADVISOR OR REGISTERED BROKER. Raging Bull, or any of their owners, employees or independent contractors is currently registered as a securities broker-dealer, broker, investment advisor (IA), or IA representative with the U.S. Securities and Exchange Commission, any state securities regulatory authority, or any self-regulatory organization.
USE OF FORWARD-LOOKING STATEMENTS. Certain statements made in this advertisement may constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and 21E of the Exchange Act of 1934. Forward-looking statements often include words such as “believes,” “anticipates,” “estimates,” “expects,” “projects,” “intends,” or other similar expressions of future performance or conduct. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made and are not statements of historical fact. They involve many risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. There is no guarantee that past performance will be indicative of future results. Raging Bull does not undertake an obligation to update forward-looking statements in light of new information or future events. Readers can and should review all public SEC filings made by the companies profiled in the Advertisements at https:// www. sec .gov/edgar/searchedgar/companysearch
TRADEMARKS. All trademarks used in this advertisement are the property of their respective trademark holders and no endorsement by such owners of the contents of the advertisement is made or implied.
WE MAY HOLD SECURITIES DISCUSSED. Ragingbull.com, LLC, its owners, and its employees may purchase, sell, or hold long or short positions in securities of the companies mentioned in this communication.
DISCLAIMER: To more fully understand any Ragingbull.com, LLC (“RagingBull”) subscription, website, application or other service (“Services”), please review our full disclaimer located at https:// ragingbull. com/disclaimer.
RESULTS PRESENTED NOT TYPICAL OR VERIFIED. RagingBull Services may contain information regarding the historical trading performance of RagingBull owners or employees, and/or testimonials of non-employees depicting profitability that are believed to be true based on the representations of the persons voluntarily providing the testimonial. However, subscribers’ trading results have NOT been tracked or verified and past performance is not necessarily indicative of future results, and the results presented in this communication are NOT TYPICAL. Actual results will vary widely given a variety of factors such as experience, skill, risk mitigation practices, market dynamics and the amount of capital deployed. Investing in securities is speculative and carries a high degree of risk; you may lose some, all, or possibly more than your original investment.
